Nautilus, Inc. Reports Fiscal Second Quarter 2023 Results
Nautilus, Inc. reported Q2 fiscal 2023 results with net sales of $65.5M, a decrease of 52.6% from last year but 24% higher than the pre-pandemic period. Direct segment sales rose 51% versus Q2 fiscal 2020, while the JRNY® fitness platform reached about 400,000 members, growing 116% year-over-year. Gross profit margins fell to 17.5%, impacting overall profit, with a net loss of $13.2M, or $0.41 per diluted share. The company adjusted its full-year guidance, expecting growth in the second half of the fiscal year, despite challenges in the retail sector.
- Direct segment sales increased 51% compared to pre-pandemic levels.
- JRNY® membership grew to approximately 400,000, a 116% increase year-over-year.
- Adjusted EBITDA loss reduced by 50% from the previous year.
- Net sales down 52.6% compared to last year.
- Gross profit declined to 17.5% from 30.5% year-over-year.
- Net loss of $13.2M, or $0.41 per diluted share.
Direct Segment
JRNY® Total Members Reaches Approximately 400k with
Gross Margin Improves Sequentially from Prior Quarter by 480 basis points; Adjusted EBITDA Loss reduced by 50%
The Company Updates Full Year Guidance
Management Comments
“Our omnichannel business model enabled us to deliver Q2 revenue growth of
Total Company Results
For fiscal 2023, Nautilus expects to return to a more typical pre-pandemic seasonality, with the 2nd Half of the year contributing more of the full year's revenue. Additionally, to gauge sales growth and progress against more "normalized" or pre-pandemic results, the Company will rely more heavily on measuring performance of fiscal 2023 sales growth versus the pre-pandemic twelve-month period that ended
Fiscal 2023 Second Quarter Ended
-
Net sales were
, compared to$65.5 million , a decline of$138.0 million 52.6% versus last year. Net sales are up24% , or7% Compound Annual Growth Rate ("CAGR"), when compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold inOctober 2020 . The sales decline versus last year is driven primarily by the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices, as our typical sales discounts were largely unnecessary during the pandemic period. -
Gross profit was
, compared to$11.5 million last year. Gross profit margins were$42.1 million 17.5% compared to30.5% last year. The 13.0 ppt decrease in gross margins was primarily due to increased discounting (-4 ppts), unfavorable logistics overhead absorption (-4 ppts), increased investments in JRNY® (-3 ppts), a prior year release of a special warranty reserve (-2 ppts), and an increase in inventory adjustments (-2 ppts), partially offset by improvement in other costs (+2 ppts). -
Operating expenses were
compared to$25.8 million last year. The decrease of$44.0 million , or$18.2 million 41.4% , was primarily due to lower media spending, a$9.3 million prior year loss contingency related to a legal settlement, a decrease of$4.7 million due to other cost savings, and a$3.0 million decrease in other variable selling and marketing expenses due to decreased sales, offset by a$2.7 million increase in JRNY® investments. Total advertising expenses were$1.5 million versus$3.1 million last year.$12.4 million -
Operating loss was
or a negative$14.3 million 21.8% operating margin, compared to an operating loss of last year, primarily driven by lower gross profit.$2.0 million -
Income tax expense was
this year compared to$0.2 million last year. The income tax expense this quarter was primarily a result of a$2.2 million U.S. deferred tax asset valuation allowance in the amount of recorded in the second quarter of fiscal 2023.$3.6 million -
Loss from continuing operations was
, or$15.3 million per diluted share, compared to$0.48 , or$4.6 million per diluted share, last year.$0.15 -
Net loss was
, or$13.2 million per diluted share, compared to net loss of$0.41 or$4.6 million per diluted share, last year.$0.15 -
The following statements exclude the impact of legal settlement and acquisition and other related costs1 for the three-months ended
September 30, 2021 .-
Adjusted operating expenses were
compared to$25.2 million last year. The$38.5 million or$13.4 million 34.7% decrease was primarily due to lower media spending, a decrease of$9.3 million due to other cost savings, and a$2.4 million decrease in other variable selling and marketing expenses due to decreased sales, partially offset by a$2.7 million increase in JRNY® investments.$1.1 million -
Adjusted operating loss was
compared to last year’s income of$13.7 million , driven by lower gross profit.$3.5 million -
Adjusted EBITDA loss from continuing operations was
compared to income of$9.8 million last year.$7.0 million
-
Adjusted operating expenses were
1 See “Reconciliation of Non-GAAP Financial Measures” for more information
Six-Months Ended
-
Net sales were
, compared to$120.3 million , a decline of$322.6 million 62.7% versus last year. Net sales are up17% , or5% CAGR, when compared to the same period in fiscal 2020, excluding sales related to the Octane brand, which was sold inOctober 2020 . The sales decline versus last year is driven primarily by the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices, as our typical sales discounts were largely unnecessary during the pandemic period. -
Gross profit was
, compared to$18.4 million last year. Gross profit margins were$97.6 million 15.3% compared to30.3% last year. The 15.0 ppt decrease in gross margins was primarily due to increased discounting (-7 ppts), unfavorable logistics overhead absorption (-6 ppts), increased investments in JRNY® (-3 ppts), an increase in inventory adjustments (-2 ppts), partially offset by improvements in other costs (+3 ppts). -
Operating expenses were
compared to$83.9 million last year. The increase of$81.6 million , or$2.3 million 2.8% , was primarily due to a goodwill and intangible impairment charge of and a$27.0 million increase in JRNY® investments, offset by a$5.0 million decrease in media spending, a$15.2 million decrease in other variable selling and marketing expenses due to decreased sales, a decrease of$5.2 million due to savings in other operating expenses, and a$4.6 million prior year loss contingency for a legal settlement. Total advertising expenses were$4.7 million versus$8.8 million last year.$24.0 million -
Operating loss was
or a negative$65.5 million 54.5% operating margin, compared to operating income of last year, primarily driven by a goodwill and intangible impairment charge of$15.9 million and lower gross profit associated with lower sales demand during the period.$27.0 million -
Income tax expense was
this year compared to$8.3 million last year. The income tax expense in the current year was primarily a result of a$5.7 million U.S. deferred tax asset valuation allowance in the amount of recorded against our domestic uncovered net deferred tax assets to reduce our deferred tax assets to an anticipated realizable value.$17.8 million -
Loss from continuing operations was
, or$75.5 million per diluted share, compared to income of$2.40 , or$9.4 million per diluted share, last year.$0.29 -
Net loss was
, or$73.4 million per diluted share, compared to net income of$2.33 or$9.3 million per diluted share, last year.$0.29 -
The following statements exclude the impact of non-cash impairment charges1 related to the carrying value of our goodwill and intangible assets for the six-months ended
September 30, 2022 and the impact of legal settlement and acquisition and other related costs1 for the six months endedSeptember 30, 2021 .-
Adjusted operating expenses were
compared to$55.7 million last year. The$75.9 million or$20.3 million 26.7% decrease was driven by lower media spending, a$15.2 million decrease in other variable selling and marketing expenses due to decreased sales, a decrease of$5.2 million due to savings in other operating expenses, partially offset by a$3.8 million increase in JRNY® investments.$4.0 million -
Adjusted operating loss was
compared to last year’s income of$37.3 million , driven by lower gross profit.$21.6 million -
Adjusted EBITDA loss from continuing operations was
compared to income of$29.1 million last year.$28.4 million
-
Adjusted operating expenses were
1 See “Reconciliation of Non-GAAP Financial Measures” for more information
JRNY® Update
- Nautilus continues to enhance the JRNY® platform through many unique features including the expansion of differentiated visual connected-fitness experiences for JRNY® Members.
-
As of
September 30, 2022 , members of JRNY®, Nautilus’ personalized connected fitness platform, reached 396,000 representing approximately116% growth versus the same quarter last year. Of these members, 142,000 were Subscribers, representing approximately258% growth over the same period. We define JRNY® Members as all individuals who have a JRNY® account and/or subscription, which includes Subscribers, their respective associated users, and users who consume free content. We define Subscribers as a person or household who paid for a Subscription, are in a trial, or have requested a "pause"' to their subscriptions for up to three months. -
Additionally, we made great strides over the last two years, expanding the number of products featuring JRNY® connectivity. In fiscal 2022, approximately
80% of total units sold were JRNY® compatible, compared to only22% in the pre-pandemic fiscal 2020. The trend of approximately80% of total units sold being JRNY® compatible continued in the first two quarters of fiscal 2023. - In the last two months, we’ve expanded our cardio offerings to include the Bowflex® BXT8J treadmill, along with the Schwinn® 190 upright bike and 290 recumbent bike. Prioritizing quality and compelling features at an affordable price point, all three products offer high-performance cardio combined with digital connectivity to the JRNY® adaptive fitness platform, paired via a user’s device.
- Nautilus' integration of VAY's motion-tracking capabilities into JRNY® will further advance and accelerate personalized strength workout options, including the addition of rep counting and form coaching for SelectTech® users, which we believe will drive JRNY® membership growth during the back-half of fiscal 2023.
Segment Results
Fiscal 2023 Second Quarter Ended
Direct Segment
-
Direct segment sales were
, compared to$24.5 million , a decline of$37.9 million 35.3% versus last year, and up51.1% , or15% CAGR, compared to the same period in fiscal 2020. The net sales decrease compared to last year was primarily driven by the return to pre-pandemic seasonal demand and pre-pandemic sales discounting practices. -
Cardio sales declined
26.4% versus last year and were up32.7% , or10% CAGR, compared to the same period in fiscal 2020. Lower sales this quarter were primarily driven by lower bike demand. Strength product sales declined48.3% versus last year and increased112.1% , or28% CAGR, compared to the same period in fiscal 2020. Lower sales this quarter were primarily driven by lower demand for SelectTech® weights. -
As of
September 30, 2022 , the Direct segment's backlog totaled . This amount represents unfulfilled consumer orders net of current promotional programs and sales discounts.$0.3 million -
Gross profit margin was
12.7% versus36.9% last year. The 24.2 ppt decrease in gross margin was primarily driven by: increased discounting (-7 ppts), increased investments in JRNY® (-5 ppts), a prior year release of a special warranty reserve (-4 ppts), unfavorable logistics overhead absorption (-4 ppts), and increases in other costs (-4 ppts). Gross profit was , a decrease of$3.1 million 77.8% versus last year. -
Segment contribution loss was
, or$7.9 million 32.2% of sales, compared to segment contribution loss of , or$1.8 million 4.8% of sales last year. The decline was primarily driven by lower gross profit, as explained above, offset by decreased media spend. Advertising expenses were compared to$2.6 million for the same period last year.$6.8 million
Retail Segment
-
Retail segment sales were
, compared to$39.9 million , a decline of$99.2 million 59.8% versus last year, and up10.6% , or3% CAGR, compared to the same period in fiscal 2020 excluding sales related to the Octane brand. Retail segment sales outsidethe United States andCanada were down80.0% versus last year. The net sales decrease compared to last year is primarily driven by lower cardio sales as retailers work through higher-than-normal inventory levels. -
Cardio sales declined
75.3% versus last year and were down45.7% , or18% CAGR, compared to the same period in fiscal 2020, excluding sales related to the Octane brand. Lower sales this quarter were primarily driven by lower bike demand. Strength product sales declined37.1% versus last year and increased172.2% or40% CAGR, compared to the same period in fiscal 2020. Lower sales this quarter were primarily driven by lower demand for SelectTech® weights. -
As of
September 30, 2022 , the Retail segment's backlog totaled . This amount represents customer orders for future shipments and are net of contractual rebates and consideration payable to applicable Retail customers.$32.6 million -
Gross profit margin was
18.3% versus27.4% last year. The 9.1 ppt decrease in gross margin was primarily driven by: an increase in inventory adjustment (-4 ppts), increased discounting (-3 ppts) and unfavorable logistics overhead absorption (-3 ppts), partially offset by improvements in other costs (+1 ppt). Gross profit was , a decrease of$7.3 million 73% versus last year. -
Segment contribution loss was
, or$1.0 million 2.4% of sales, compared to segment contribution income of , or$18.7 million 18.9% of sales, last year. The decline was primarily driven by lower gross profit as explained above.
Comparison of Segment Results for the Six-Months Ended
Direct Segment
-
Direct segment sales were
, compared to$51.0 million , a decline of$101.2 million 49.7% versus last year, and up37.6% , or11% CAGR, compared to the same period in fiscal 2020. The net sales decrease compared to last year was primarily driven by the return to pre-pandemic seasonal demand and higher sales discounting practices. -
Cardio sales declined
37.5% versus last year and were up17.9% , or6% CAGR, compared to the same period in fiscal 2020. Lower sales were primarily driven by lower bike demand. Strength product sales declined63.4% versus last year and increased103.5% , or27% CAGR, compared to the same period in fiscal 2020. Lower sales this year were primarily driven by lower demand for SelectTech® weights. -
Gross profit margin was
15.0% versus38.0% last year. The 23.0 ppt decrease in gross margin was primarily due to increased discounting (-8 ppts), increased investments in JRNY® (-6 ppts), unfavorable logistics overhead absorption (-6 ppts), a prior year release of a special warranty reserve (-2 ppts) and increased inventory reserves (-1 ppt). Gross profit was , down$7.7 million 80.1% versus last year. -
Segment contribution loss was
, or$17.8 million 34.9% of sales, compared to segment contribution income of , or$4.9 million 4.9% of sales last year. The decline was primarily driven by lower gross profit, as explained above, offset by decreased media spend. Advertising expenses were compared to$7.8 million for the same period last year.$14.8 million
Retail Segment
-
Retail segment sales were
, compared to$67.3 million , a decline of$219.6 million 69.3% versus last year and up5.1% , or2% CAGR, compared to the same period in fiscal 2020, excluding sales related to the Octane brand. Retail segment sales outsidethe United States andCanada were down82% versus last year. The net sales decrease compared to last year is primarily driven by lower cardio sales and higher sales discounting as retailers work through higher-than-normal inventory levels. -
Cardio sales declined
82.3% versus last year and were down39.2% , or15% CAGR, compared to the same period in fiscal 2020, excluding sales related to the Octane brand. Lower sales this year were primarily driven by lower bike demand. Strength product sales declined by42.2% versus last year and increased97.6% or25% CAGR, compared to the same period in fiscal 2020. Lower sales this year were primarily driven by lower demand for SelectTech® weights. -
Gross profit margin was
13.0% versus26.1% last year. The 13.1 ppt decrease in gross margin was primarily due to increased discounting (-6 ppts), unfavorable logistics overhead absorption (-6 ppts) and increase in inventory adjustments (-3 ppts), partially offset by improvements in other costs (+2 ppts). Gross profit was , a decrease of$8.8 million 85% versus last year. -
Segment contribution loss was
, or$4.4 million 6.6% of sales, compared to segment contribution income of , or$40.8 million 18.6% of sales, last year. The decline was primarily driven by lower gross profit as explained above.
Balance Sheet and Other Key Highlights as of
-
Cash and Liquidity:
-
Cash, cash equivalents, and restricted cash were
, compared to cash, cash equivalents, and restricted cash of$6.8 million as of$14.2 million March 31, 2022 . The decrease was primarily due to the net loss, offset by increased debt and changes in working capital. -
Debt and other borrowings were
compared to$47.0 million as of$29.4 million March 31, 2022 . -
was available for borrowing under the Wells Fargo Asset Based Lending Revolving Facility (“Facility”) compared to$22.2 million as of$65.8 million March 31, 2022 .
-
Cash, cash equivalents, and restricted cash were
-
Inventory was
, down$99.2 million 11% compared to as of$111.2 million March 31, 2022 and down39% versus the same quarter last year. The year-over-year decrease in inventory was driven by sell-through and strong inventory management as the Company continued to right-size inventory levels. About11% of inventory as ofSeptember 30, 2022 was in-transit. -
Trade receivables were
, compared to$33.7 million as of$61.5 million March 31, 2022 . The decrease in trade receivables was due to lower sales and the timing of customer payments. -
Trade payables were
, compared to$36.5 million as of$53.2 million March 31, 2022 . The decrease in trade payables was primarily due to planned reduction in inventory levels. -
Capital expenditures totaled
for the six-months ended$7.5 million September 30, 2022 .
Forward Looking Guidance
The following forward-looking statements reflect the Company's full fiscal year 2023 expectations as of
Second Half and Full Year 2023
-
The Company expects full year revenue of between
and$315 million compared to the previous range of$365 million to$380 million . The decline in revenue is primarily due to lower expectations in the Retail segment.$460 million -
The Company now expects gross margins for the second half of the year to be in the range of
24% to27% , compared to the previous range of27% to30% . The decline is primarily due to the lower revenue and the resulting loss of expense leverage of fixed costs. -
The sequential improvement in gross margins versus the first half are driven by lower in-bound freight, the elimination of detention and demurrage fees, and the reduction in logistics facilities footprint. The Company closed one of its distribution centers at lease expiration in
October 2022 and will not be renewing the leases of some storage locations in-line with the progress made to right-size inventory levels. -
The Company remains focused on achieving break-even Adjusted EBITDA for the 2nd Half of fiscal 2023 to minimize cash consumption and begin the return to profitability. However, given the wide range of revenue expectations driven by the current macro-economic environment, the Company is now guiding to full year Adjusted EBITDA(1) loss to be between
and$30 million compared to the prior range of Adjusted EBITDA(1) loss of between$40 million and$25 million .$35 million -
The Company continues to expect JRNY® Members to exceed 500,000 at
March 31, 2023 .
(1) We provide Adjusted EBITDA guidance, rather than net income guidance, due to the inherent unpredictability of forecasting certain types of expenses such as stock-based compensation and income tax expenses, which affect net income but not Adjusted EBITDA. We are unable to reasonably estimate the impact of such expenses, if any, on net income. The inability to project certain components of the calculation would significantly affect the accuracy of a reconciliation. Accordingly, we do not provide a reconciliation of projected net income to projected Adjusted EBITDA.
Conference Call
Nautilus will discuss our fiscal 2023 second quarter ended
A telephonic playback will be available from
About
Headquartered in
Forward-Looking Statements
This press release includes forward-looking statements (statements which are not historical facts) within the meaning of the Private Securities Litigation Reform Act of 1995, including: projected, targeted or forecasted financial, operating results and capital expenditures, including but not limited to net sales growth rates, gross margins, operating expenses, operating margins, anticipated demand for the Company's new and existing products, statements regarding the Company's prospects, resources or capabilities; planned investments, strategic initiatives and the anticipated or targeted results of such initiatives; the effects of the COVID-19 pandemic on the Company’s business; and planned operational initiatives and the anticipated cost-saving results of such initiatives. All of these forward-looking statements are subject to risks and uncertainties that may change at any time. Factors that could cause Nautilus, Inc.’s actual expectations to differ materially from these forward-looking statements also include: weaker than expected demand for new or existing products; our ability to timely acquire inventory that meets our quality control standards from sole source foreign manufacturers at acceptable costs; risks associated with current and potential delays, work stoppages, or supply chain disruptions, including shipping delays due to the severe shortage of shipping containers; an inability to pass along or otherwise mitigate the impact of raw material price increases and other cost pressures, including unfavorable currency exchange rates and increased shipping costs; experiencing delays and/or greater than anticipated costs in connection with launch of new products, entry into new markets, or strategic initiatives; our ability to hire and retain key management personnel; changes in consumer fitness trends; changes in the media consumption habits of our target consumers or the effectiveness of our media advertising; a decline in consumer spending due to unfavorable economic conditions; risks related to the impact on our business of the COVID-19 pandemic or similar public health crises; softness in the retail marketplace; availability and timing of capital for financing our strategic initiatives, including being able to raise capital on favorable terms or at all; changes in the financial markets, including changes in credit markets and interest rates that affect our ability to access those markets on favorable terms and the impact of any future impairment. Additional assumptions, risks and uncertainties are described in detail in our registration statements, reports and other filings with the
RESULTS OF OPERATIONS INFORMATION
The following summary contains information from our consolidated statements of operations for the three and six-month periods ended
|
Three-Months Ended
|
|
Six-Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Net sales |
$ |
65,458 |
|
|
$ |
137,959 |
|
|
$ |
120,275 |
|
|
$ |
322,552 |
|
Cost of sales |
|
54,000 |
|
|
|
95,906 |
|
|
|
101,859 |
|
|
|
224,994 |
|
Gross profit |
|
11,458 |
|
|
|
42,053 |
|
|
|
18,416 |
|
|
|
97,558 |
|
Operating expenses: |
|
|
|
|
|
|
|
||||||||
Selling and marketing |
|
9,400 |
|
|
|
21,939 |
|
|
|
22,290 |
|
|
|
43,239 |
|
General and administrative |
|
10,995 |
|
|
|
16,376 |
|
|
|
23,458 |
|
|
|
27,899 |
|
Research and development |
|
5,405 |
|
|
|
5,688 |
|
|
|
11,229 |
|
|
|
10,503 |
|
|
|
— |
|
|
|
— |
|
|
|
26,965 |
|
|
|
— |
|
Total operating expenses |
|
25,800 |
|
|
|
44,003 |
|
|
|
83,942 |
|
|
|
81,641 |
|
|
|
|
|
|
|
|
|
||||||||
Operating (loss) income |
|
(14,342 |
) |
|
|
(1,950 |
) |
|
|
(65,526 |
) |
|
|
15,917 |
|
Other expense, net |
|
(815 |
) |
|
|
(375 |
) |
|
|
(1,705 |
) |
|
|
(788 |
) |
(Loss) income from continuing operations before income taxes |
|
(15,157 |
) |
|
|
(2,325 |
) |
|
|
(67,231 |
) |
|
|
15,129 |
|
Income tax expense |
|
156 |
|
|
|
2,242 |
|
|
|
8,251 |
|
|
|
5,680 |
|
(Loss) income from continuing operations |
|
(15,313 |
) |
|
|
(4,567 |
) |
|
|
(75,482 |
) |
|
|
9,449 |
|
Income (loss) from discontinued operations, net of income taxes |
|
2,110 |
|
|
|
(35 |
) |
|
|
2,102 |
|
|
|
(167 |
) |
Net (loss) income |
$ |
(13,203 |
) |
|
$ |
(4,602 |
) |
|
$ |
(73,380 |
) |
|
$ |
9,282 |
|
|
|
|
|
|
|
|
|
||||||||
Basic (loss) income per share from continuing operations |
$ |
(0.48 |
) |
|
$ |
(0.15 |
) |
|
$ |
(2.40 |
) |
|
$ |
0.31 |
|
Basic income (loss) per share from discontinued operations |
|
0.07 |
|
|
|
— |
|
|
|
0.07 |
|
|
|
(0.01 |
) |
Basic net (loss) income per share |
$ |
(0.41 |
) |
|
$ |
(0.15 |
) |
|
$ |
(2.33 |
) |
|
$ |
0.30 |
|
|
|
|
|
|
|
|
|
||||||||
Diluted (loss) income per share from continuing operations |
$ |
(0.48 |
) |
|
$ |
(0.15 |
) |
|
$ |
(2.40 |
) |
|
$ |
0.29 |
|
Diluted income per share from discontinued operations |
|
0.07 |
|
|
|
— |
|
|
|
0.07 |
|
|
|
— |
|
Diluted net (loss) income per share |
$ |
(0.41 |
) |
|
$ |
(0.15 |
) |
|
$ |
(2.33 |
) |
|
$ |
0.29 |
|
|
|
|
|
|
|
|
|
||||||||
Shares used in per share calculations: |
|
|
|
|
|
|
|
||||||||
Basic |
|
31,585 |
|
|
|
30,968 |
|
|
|
31,496 |
|
|
|
30,833 |
|
Diluted |
|
31,585 |
|
|
|
30,968 |
|
|
|
31,496 |
|
|
|
32,437 |
|
|
|
|
|
|
|
|
|
||||||||
Select Metrics: |
|
|
|
|
|
|
|
||||||||
Gross margin |
|
17.5 |
% |
|
|
30.5 |
% |
|
|
15.3 |
% |
|
|
30.2 |
% |
Selling and marketing % of net sales |
|
14.4 |
% |
|
|
15.9 |
% |
|
|
18.5 |
% |
|
|
13.4 |
% |
General and administrative % of net sales |
|
16.8 |
% |
|
|
11.9 |
% |
|
|
19.5 |
% |
|
|
8.6 |
% |
Research and development % of net sales |
|
8.3 |
% |
|
|
4.1 |
% |
|
|
9.3 |
% |
|
|
3.3 |
% |
Operating (loss) income % of net sales |
|
(21.9 |
) % |
|
|
(1.4 |
) % |
|
|
(54.5 |
) % |
|
|
4.9 |
% |
SEGMENT INFORMATION
The following table presents certain comparative information by segment and major product lines within each business segment for the three and six-months ended
|
Three-Months Ended
|
|
Change |
|||||||||||
|
2022 |
|
2021 |
|
$ |
|
% |
|||||||
Net sales: |
|
|
|
|
|
|
|
|||||||
Direct net sales: |
|
|
|
|
|
|
|
|||||||
Cardio products(1) |
$ |
16,493 |
|
|
$ |
22,406 |
|
|
$ |
(5,913 |
) |
|
(26.4 |
) % |
Strength products(2) |
|
7,987 |
|
|
|
15,447 |
|
|
|
(7,460 |
) |
|
(48.3 |
) % |
Direct |
|
24,480 |
|
|
|
37,853 |
|
|
|
(13,373 |
) |
|
(35.3 |
) % |
|
|
|
|
|
|
|
|
|||||||
Retail net sales: |
|
|
|
|
|
|
|
|||||||
Cardio products(1) |
|
14,554 |
|
|
|
58,848 |
|
|
|
(44,294 |
) |
|
(75.3 |
) % |
Strength products(2) |
|
25,351 |
|
|
|
40,305 |
|
|
|
(14,954 |
) |
|
(37.1 |
) % |
Retail |
|
39,905 |
|
|
|
99,153 |
|
|
|
(59,248 |
) |
|
(59.8 |
) % |
|
|
|
|
|
|
|
|
|||||||
Royalty |
|
1,073 |
|
|
|
953 |
|
|
|
120 |
|
|
12.6 |
% |
Consolidated net sales |
$ |
65,458 |
|
|
$ |
137,959 |
|
|
$ |
(72,501 |
) |
|
(52.6 |
) % |
|
|
|
|
|
|
|
|
|||||||
Gross profit: |
|
|
|
|
|
|
|
|||||||
Direct |
$ |
3,101 |
|
|
$ |
13,976 |
|
|
$ |
(10,875 |
) |
|
(77.8 |
) % |
Retail |
|
7,284 |
|
|
|
27,124 |
|
|
|
(19,840 |
) |
|
(73.1 |
) % |
Royalty |
|
1,073 |
|
|
|
953 |
|
|
|
120 |
|
|
12.6 |
% |
Consolidated gross profit |
$ |
11,458 |
|
|
$ |
42,053 |
|
|
$ |
(30,595 |
) |
|
(72.8 |
) % |
|
|
|
|
|
|
|
|
|||||||
Gross margin: |
|
|
|
|
|
|
|
|||||||
Direct |
|
12.7 |
% |
|
|
36.9 |
% |
|
|
(2,420 |
) |
basis points |
||
Retail |
|
18.3 |
% |
|
|
27.4 |
% |
|
|
(910 |
) |
basis points |
||
|
|
|
|
|
|
|
|
|||||||
Contribution: |
|
|
|
|
|
|
|
|||||||
Direct |
$ |
(7,887 |
) |
|
$ |
(1,835 |
) |
|
$ |
(6,052 |
) |
|
(329.8 |
) % |
Retail |
|
966 |
|
|
|
18,741 |
|
|
|
(17,775 |
) |
|
(94.8 |
) % |
Royalty |
|
1,073 |
|
|
|
953 |
|
|
|
120 |
|
|
12.6 |
% |
Consolidated contribution |
$ |
(5,848 |
) |
|
$ |
17,859 |
|
|
$ |
(23,707 |
) |
|
(132.7 |
) % |
|
|
|
|
|
|
|
|
|||||||
Reconciliation of consolidated contribution to loss from continuing operations: |
|
|
||||||||||||
Consolidated contribution |
$ |
(5,848 |
) |
|
$ |
17,859 |
|
|
$ |
(23,707 |
) |
|
(132.7 |
) % |
Amounts not directly related to segments: |
|
|
|
|
|
|
|
|||||||
Operating expenses |
|
(8,493 |
) |
|
|
(19,809 |
) |
|
|
11,316 |
|
|
57.1 |
% |
Other expense, net |
|
(816 |
) |
|
|
(375 |
) |
|
|
(441 |
) |
|
(117.6 |
) % |
Income tax expense |
|
(156 |
) |
|
|
(2,242 |
) |
|
|
2,086 |
|
|
93.0 |
% |
Loss from continuing operations |
$ |
(15,313 |
) |
|
$ |
(4,567 |
) |
|
$ |
(10,746 |
) |
|
(235.3 |
) % |
(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, Bowflex® VeloCore®, Schwinn® IC4, |
||||||||||||||
(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories. |
|
Six-Months Ended
|
|
Change |
|||||||||||
|
2022 |
|
2021 |
|
$ |
|
% |
|||||||
Net sales: |
|
|
|
|
|
|
|
|||||||
Direct net sales: |
|
|
|
|
|
|
|
|||||||
Cardio products(1) |
$ |
33,626 |
|
|
$ |
53,836 |
|
|
$ |
(20,210 |
) |
|
(37.5 |
) % |
Strength products(2) |
|
17,331 |
|
|
|
47,413 |
|
|
|
(30,082 |
) |
|
(63.4 |
) % |
Direct |
|
50,957 |
|
|
|
101,249 |
|
|
|
(50,292 |
) |
|
(49.7 |
) % |
|
|
|
|
|
|
|
|
|||||||
Retail net sales: |
|
|
|
|
|
|
|
|||||||
Cardio products(1) |
|
26,397 |
|
|
|
148,772 |
|
|
|
(122,375 |
) |
|
(82.3 |
) % |
Strength products(2) |
|
40,951 |
|
|
|
70,865 |
|
|
|
(29,914 |
) |
|
(42.2 |
) % |
Retail |
|
67,348 |
|
|
|
219,637 |
|
|
|
(152,289 |
) |
|
(69.3 |
) % |
|
|
|
|
|
|
|
|
|||||||
Royalty |
|
1,970 |
|
|
|
1,666 |
|
|
|
304 |
|
|
18.2 |
% |
Consolidated net sales |
$ |
120,275 |
|
|
$ |
322,552 |
|
|
$ |
(202,277 |
) |
|
(62.7 |
) % |
|
|
|
|
|
|
|
|
|||||||
Gross profit: |
|
|
|
|
|
|
|
|||||||
Direct |
$ |
7,665 |
|
|
$ |
38,490 |
|
|
$ |
(30,825 |
) |
|
(80.1 |
) % |
Retail |
|
8,781 |
|
|
|
57,402 |
|
|
|
(48,621 |
) |
|
(84.7 |
) % |
Royalty |
|
1,970 |
|
|
|
1,666 |
|
|
|
304 |
|
|
18.2 |
% |
Consolidated gross profit |
$ |
18,416 |
|
|
$ |
97,558 |
|
|
$ |
(79,142 |
) |
|
(81.1 |
) % |
|
|
|
|
|
|
|
|
|||||||
Gross margin: |
|
|
|
|
|
|
|
|||||||
Direct |
|
15.0 |
% |
|
|
38.0 |
% |
|
|
(2,300 |
) |
basis points |
||
Retail |
|
13.0 |
% |
|
|
26.1 |
% |
|
|
(1,310 |
) |
basis points |
||
|
|
|
|
|
|
|
|
|||||||
Contribution: |
|
|
|
|
|
|
|
|||||||
Direct |
$ |
(17,780 |
) |
|
$ |
4,924 |
|
|
$ |
(22,704 |
) |
|
(461.1 |
) % |
Retail |
|
(4,442 |
) |
|
|
40,831 |
|
|
|
(45,273 |
) |
|
(110.9 |
) % |
Royalty |
|
1,970 |
|
|
|
1,666 |
|
|
|
304 |
|
|
18.2 |
% |
Consolidated contribution |
$ |
(20,252 |
) |
|
$ |
47,421 |
|
|
$ |
(67,673 |
) |
|
(142.7 |
) % |
|
|
|
|
|
|
|
|
|||||||
Reconciliation of consolidated contribution to (loss) income from continuing operations: |
|
|
||||||||||||
Consolidated contribution |
$ |
(20,252 |
) |
|
$ |
47,421 |
|
|
$ |
(67,673 |
) |
|
(142.7 |
) % |
Amounts not directly related to segments: |
|
|
|
|
|
|
|
|||||||
Operating expenses |
|
(45,274 |
) |
|
|
(31,504 |
) |
|
|
(13,770 |
) |
|
(43.7 |
) % |
Other expense, net |
|
(1,704 |
) |
|
|
(788 |
) |
|
|
(916 |
) |
|
(116.2 |
) % |
Income tax expense |
|
(8,252 |
) |
|
|
(5,680 |
) |
|
|
(2,572 |
) |
|
(45.3 |
) % |
(Loss) income from continuing operations |
$ |
(75,482 |
) |
|
$ |
9,449 |
|
|
$ |
(84,931 |
) |
|
(898.8 |
) % |
(1) Cardio products include: connected-fitness bikes, the Bowflex® C6, Bowflex® VeloCore®, Schwinn® IC4, |
||||||||||||||
(2) Strength products include: Bowflex® Home Gyms, Bowflex® SelectTech® dumbbells, kettlebell and barbell weights, and accessories. |
BALANCE SHEET INFORMATION
The following summary contains information from our consolidated balance sheets as of
|
As of |
||||||
|
|
|
|
||||
Assets |
|
|
|
||||
|
|
|
|
||||
Cash and cash equivalents |
$ |
5,805 |
|
$ |
12,872 |
||
Restricted cash |
|
946 |
|
|
|
1,339 |
|
Trade receivables, net of allowances |
|
33,662 |
|
|
|
61,454 |
|
Inventories |
|
99,210 |
|
|
|
111,190 |
|
Prepaids and other current assets |
|
10,124 |
|
|
|
14,546 |
|
Other current assets - restricted, current |
|
3,887 |
|
|
|
3,887 |
|
Income taxes receivable |
|
1,658 |
|
|
|
1,998 |
|
Total current assets |
|
155,292 |
|
|
|
207,286 |
|
Property, plant and equipment, net |
|
34,182 |
|
|
|
32,129 |
|
Operating lease right-of-use assets |
|
21,085 |
|
|
|
23,620 |
|
|
|
— |
|
|
|
24,510 |
|
Other intangible assets, net |
|
6,818 |
|
|
|
9,304 |
|
Deferred income tax assets, non-current |
|
758 |
|
|
|
8,760 |
|
Income taxes receivable, non-current |
|
5,673 |
|
|
|
5,673 |
|
Other assets |
|
2,705 |
|
|
|
2,763 |
|
Total assets |
$ |
226,513 |
|
|
$ |
314,045 |
|
|
|
|
|
||||
Liabilities and Shareholders' Equity |
|
|
|
||||
|
|
|
|
||||
Trade payables |
$ |
36,542 |
|
|
$ |
53,165 |
|
Accrued liabilities |
|
19,957 |
|
|
|
29,386 |
|
Operating lease liabilities, current portion |
|
4,057 |
|
|
|
4,494 |
|
Finance lease liabilities, current portion |
|
121 |
|
|
|
119 |
|
Warranty obligations, current portion |
|
3,450 |
|
|
|
4,968 |
|
Income taxes payable, current portion |
|
536 |
|
|
|
839 |
|
Debt payable, current portion, net of unamortized debt issuance costs |
|
2,243 |
|
|
|
2,243 |
|
Total current liabilities |
|
66,906 |
|
|
|
95,214 |
|
Operating lease liabilities, non-current |
|
18,619 |
|
|
|
20,926 |
|
Finance lease liabilities, non-current |
|
339 |
|
|
|
395 |
|
Warranty obligations, non-current |
|
900 |
|
|
|
1,248 |
|
Income taxes payable, non-current |
|
1,943 |
|
|
|
4,029 |
|
Deferred income tax liabilities, non-current |
|
313 |
|
|
|
— |
|
Other non-current liabilities |
|
1,081 |
|
|
|
1,071 |
|
Debt payable, non-current, net of unamortized debt issuance costs |
|
44,793 |
|
|
|
27,113 |
|
Shareholders' equity |
|
91,619 |
|
|
|
164,049 |
|
Total liabilities and shareholders' equity |
$ |
226,513 |
|
|
$ |
314,045 |
|
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
Non-GAAP Presentation
Nautilus presents non-GAAP financial measures as a complement to results provided in accordance with GAAP, and the non-GAAP financial measures should not be regarded as a substitute for GAAP.
In addition to disclosing its financial results determined in accordance with GAAP, Nautilus has presented in this release certain non-GAAP financial measures, which exclude the impact of certain items (as further described below). Management believes these measures are also useful to investors as these are the same metrics that management uses to evaluate past performance and prospects for future performance. Nautilus strongly encourages investors to review all its financial statements and publicly filed reports in their entirety and to not rely on any single financial measure to evaluate the Company’s performance.
Adjusted Results
In addition to disclosing the comparable GAAP results, Nautilus has presented its operating expenses and operating (loss) income on an adjusted basis to exclude certain non-recurring items, including the non-cash charge related to goodwill and intangible asset impairment(1), the legal settlement(2), and acquisition and other related costs(3). The Company believes that excluding these items, which are inconsistent in amount and frequency, supplements the GAAP information with a measure that can be used to assess the sustainability of the Company’s operating performance. Nautilus has also presented EBITDA from continuing operations on an adjusted basis, excluding the aforementioned items for similar reasons.
Adjusted EBITDA from Continuing Operations
Nautilus has also presented EBITDA from continuing operations on an adjusted basis, to exclude the non-cash charge related to goodwill and intangible asset impairment(1), the legal settlement(2), and acquisition and other related costs(3), depreciation, amortization, and stock-based compensation and other net expenses. The Company believes that EBITDA is an important measure as it allows the company to evaluate past performance and prospects for future performance. The Company believes the exclusion of stock-based compensation expense provides for a better comparison of operating results to prior periods and to peer companies as the calculations of stock-based compensation vary from period to period and company to company due to different valuation methodologies, subjective assumptions, and the variety of award types. The Company excludes other expenses, net that are the result of factors and can vary significantly from one period to the next, we believe that exclusion of such other expenses are useful to management and investors in evaluating the performance of our ongoing operations on a period-to-period basis.
We do not reconcile non-GAAP financial measures on a forward-looking basis as it is impractical to do so without unreasonable effort.
The following table presents a reconciliation of operating expenses, the most directly comparable GAAP measure, to Adjusted operating expenses for the three and six-month periods ended
|
Three-Months Ended
|
|
Six-Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Operating expenses |
$ |
25,800 |
|
|
$ |
44,003 |
|
|
$ |
83,942 |
|
|
$ |
81,641 |
|
|
|
— |
|
|
|
— |
|
|
|
(26,965 |
) |
|
|
— |
|
Legal settlement(2) |
|
— |
|
|
|
(4,665 |
) |
|
|
— |
|
|
|
(4,665 |
) |
Acquisition and other related costs(3) |
|
(648 |
) |
|
|
(818 |
) |
|
|
(1,296 |
) |
|
|
(1,030 |
) |
Adjusted operating expenses |
$ |
25,152 |
|
|
$ |
38,520 |
|
|
$ |
55,681 |
|
|
$ |
75,946 |
|
The following table presents a reconciliation of operating (loss) income, the most directly comparable GAAP measure, to Adjusted operating (loss) income for the three and six-month periods ended
|
Three-Months Ended
|
|
Six-Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
Operating (loss) income |
$ |
(14,342 |
) |
|
$ |
(1,950 |
) |
|
$ |
(65,526 |
) |
|
$ |
15,917 |
|
|
|
— |
|
|
|
— |
|
|
|
26,965 |
|
|
|
— |
|
Legal settlement(2) |
|
— |
|
|
|
4,665 |
|
|
|
— |
|
|
|
4,665 |
|
Acquisition and other related costs(3) |
|
648 |
|
|
|
818 |
|
|
|
1,296 |
|
|
|
1,030 |
|
Adjusted operating (loss) income |
$ |
(13,694 |
) |
|
$ |
3,533 |
|
|
$ |
(37,265 |
) |
|
$ |
21,612 |
|
The following table presents a reconciliation of (loss) income from continuing operations, the most directly comparable GAAP measure, to Adjusted EBITDA from continuing operations for the three and six-month periods ended
|
Three-Months Ended
|
|
Six-Months Ended
|
||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
|
2022 |
|
|
|
2021 |
|
(Loss) income from continuing operations |
$ |
(15,313 |
) |
|
$ |
(4,567 |
) |
|
$ |
(75,482 |
) |
|
$ |
9,449 |
|
Other expense, net |
|
815 |
|
|
|
375 |
|
|
|
1,705 |
|
|
|
788 |
|
Income tax expense from continuing operations |
|
156 |
|
|
|
2,242 |
|
|
|
8,251 |
|
|
|
5,680 |
|
Depreciation and amortization |
|
2,480 |
|
|
|
1,944 |
|
|
|
4,786 |
|
|
|
3,979 |
|
Stock-based compensation expense |
|
1,367 |
|
|
|
1,540 |
|
|
|
3,346 |
|
|
|
2,765 |
|
|
|
— |
|
|
|
— |
|
|
|
26,965 |
|
|
|
— |
|
Legal settlement(2) |
|
— |
|
|
|
4,665 |
|
|
|
— |
|
|
|
4,665 |
|
Acquisition and other related costs(3) |
|
648 |
|
|
|
818 |
|
|
|
1,296 |
|
|
|
1,030 |
|
Adjusted (loss) earnings before interest, taxes, depreciation, and amortization (Adjusted EBITDA) from continuing operations |
$ |
(9,847 |
) |
|
$ |
7,017 |
|
|
$ |
(29,133 |
) |
|
$ |
28,356 |
|
(1)
In accordance with ASC 350 — Intangibles —
(2) Legal Settlement
Legal settlement is a loss contingency accrual related to a legal settlement for a class action lawsuit related to advertisement of our treadmills.
(3) Acquisition and other related costs
On
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109005938/en/
Investor Relations:
646-277-1254
John.mills@icrinc.com
Media:
360-859-5815
jfread@nautilus.com
Action Mary
925-464-8030
robin.rootenberg@actionmary.com
Source:
FAQ
What were Nautilus's Q2 fiscal 2023 results compared to the previous year?
How did Nautilus's JRNY® platform perform in Q2 fiscal 2023?
What is the outlook for Nautilus in the second half of fiscal 2023?
What were the key factors affecting Nautilus's gross profit in Q2 fiscal 2023?